Centessa Pharmaceuticals Announces Pricing of Upsized Public Offering of American Depositary Shares
09/13/24, 2:36 AM
Location
Money
$225 million
Industry
biopharma
pharmaceutical
biotechnology
health care
Type
partnership
Centessa Pharmaceuticals plc has announced the pricing of an upsized underwritten public offering of American Depositary Shares, with aggregate gross proceeds expected to be approximately $225 million.
Company Info
Location
boston, massachusetts, united states
Additional Info
Centessa Pharmaceuticals plc is a clinical-stage pharmaceutical company with a Research & Development innovation engine that aims to discover, develop and ultimately deliver impactful medicines to patients. Our programs span discovery-stage to late-stage development and cover a range of high-value indications in rare diseases and immuno-oncology. We are led by a management team with extensive R&D experience, providing direct guidance to our program teams to rapidly advance our candidates from research through all stages of development. We are headquartered in Boston, Massachusetts.